Treatment as Prevention¨

Donation largest by private citizen to single medical facility in Canadian history, foundation says. B.C. billionaire Jim Pattison has donated $75 million to the St. Paul’s Hospital Foundation in Vancouver. The St. Paul’s Foundation says the donation is the largest by a private citizen to a single medical facility in Canadian history. “Jim Pattison’s gift […]

“HIV in the Media” is part of a project Diego Mora Bello is working on as an HRC Global Fellow and a Next Generation Leader with The McCain Institute. HRC’s Global Fellows program seeks to identify outstanding established and emerging LGBTQ leaders from around the world and bring them to Washington, D.C. to work alongside

Every five years, Ryan White Care (RWC) requires its programs to prepare new plans to adjust to the changing epidemic. Biomedical advances, such as PrEP and Treatment as Prevention, have changed how people understand HIV. It has become difficult to separate HIV Prevention from Treatment. Florida’s RWC programs have submitted their new five-year plans. This

The prevalence of resistance to nonnucleoside reverse transcriptase inhibitors among HIV-infected individuals has increased to ‘alarming levels’ in Aruba, reaching 45% in 2015, researchers reported. L. Marije Hofstra, MD, of the department of medical microbiology at the University Medical Center Utrecht, the Netherlands, and colleagues discovered that the increase in resistance is due to a

We caught up with Gilead‘s Mike Elliott to find out the latest in HIV medication and whether a cure is finally within our reach… HIV capsid inhibitors – what are they and how do they work to attack the virus? Capsid inhibitors are a new class of medicines that have the potential to be used

Gilead’s latest antiretroviral drug claims lower side effects, but what about the cost? A new antiretroviral drug will soon be available to Canadian HIV patients, but it comes with a dose of controversy and likely a daunting price tag. Odefsey, the successor to the older Complera, is the latest in Gilead Sciences’ line of anti-HIV

Georgia’s HIV infection rate dropped by a 6 percent annual rate from 2008 to 2014, the Centers for Disease Control and Prevention has reported. The state Department of Health said Monday that the decline “is very encouraging news for Georgia as we work to eliminate HIV/AIDS in the state.” Dr. Patrick O’Neal, director of health